Cell Biology and function of the prion protein in health and disease

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

March 30, 2028
Response Due
Active
Status

Opportunity Overview

Creutzfeldt-Jakob disease in humans is a severe, rapidly progressive, ultimately fatal, degenerative brain disorder, caused by an infectious agent which is a misfolded version of a normal cellular protein, called the prion protein. The infectious agent replicates by converting the normal prion protein, to a misfolded disease state.

Developing cells that can propagate bona-fide human prions has been an important goal of the prion field for decades. We have successfully engineered mouse cancer cells to be able to propagate human prions from a variety of strains including the causative agent of ‘mad cow’ disease.

We aim to use these cells to develop highly sensitive and accurate automated cell-based bioassays, which can be used to measure infectious prions in a range of human tissues and bio-fluids from patients.

This assay can be a “gold standard” for diagnosis of prions and validation of other diagnostic assays and provide a biomarker for studying response to treatment. It also has the potential to be scaled up to process large numbers of samples per year, as has already been done for the mouse prion bioassay.

This is one of 1,833 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedMarch 31, 2023
Procurement stageActive solicitation
Response dueMarch 30, 2028
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 09, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Targeting the circadian clock to restore hepatitis B T-cell immunity
The mechanistic basis for the ZAP antiviral system targeting viral and cellular RNAs
Health and Demographic Surveillance System
Exploiting cochlear hydrodynamics for uniform and non-invasive drug delivery along the entire intact cochlea
Identifying HLA-bespoke changes to CD4+ T cell epitopes in influenza A virus derived antigens to drive superior protective and heterotypic immunity
Mutagenesis and its biomedical consequences
CiliaScope - Transforming Respiratory Diagnostics With AI
Elucidating rotaviral condensate structure and function for future antiviral targeting

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.